Healthcare product and device company Abbott Laboratories (NYSE:ABT) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 7.2% year on year to $10.97 billion. Its non-GAAP profit ...

Using the 2 Stage Free Cash Flow to Equity, Abbott Laboratories fair value estimate is US$152 With US$129 share price, Abbott Laboratories appears to be trading close to its estimated fair value ...

The outlook and technical action suggest Abbott Laboratories (NYSE: ABT) will lead healthcare names like Johnson & Johnson (NYSE: JNJ) higher in 2025. While each produced a solid quarter ...

In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other stocks discussed by Jim Cramer with insights on the DeepSeek AI sell-off. On the day that ...

In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against the other stocks. In his recent appearance on CNBC’s Squawk on the Street, Jim Cramer started ...

2025 Adjusted Operating Margin Forecast: 23.5% to 24% of sales. 2025 Adjusted Tax Rate Forecast: 16% to 17%. Abbott Laboratories (NYSE:ABT) achieved a 9.5% sales growth excluding COVID testing, ...

We recently published a list of im Cramer is Talking About These 10 Stocks. In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other stocks that Jim ...

Texas Gov. Greg Abbott warned Canadian Prime Minister Justin Trudeau to be “careful” about imposing a retaliatory tariff against the US in response to the tariffs levied Saturday by President ...

This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...

Governor Greg Abbott shared the news today in his State of the State address. The Texas cyber command will leverage the expertise and resources of the University of Texas at San Antonio ...